Gene · 10987
Papers2,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms. | bioRxiv | 2025 | 40799594 | PubTator, text mining | PubMed |
| A Molecular Recruitment Colocalization Platform for Visualizing Multi-Protein Interactions and Engineering Biomolecular Condensates in Living Cells. | Adv Sci (Weinh) | 2025 | 40692378 | PubTator, text mining | PubMed |
| Advances in Understanding Adaptive Hemoglobin Concentration at High Altitude. | Am J Hum Biol | 2025 | 40650341 | PubTator, text mining | PubMed |
| Recent Advances of Shikonin in the Molecular Mechanisms of Anticancer, Anti-Inflammation and Immunoregulation. | Am J Chin Med | 2025 | 40582725 | PubTator, text mining | PubMed |
| ENY2 promotes hepatocellular carcinoma progression via CSN5-mediated regulation of HDAC11 and FOXO1 signaling. | Cell Signal | 2025 | 40513846 | PubTator, text mining | PubMed |
| Green synthesis and characterization of zinc oxide nanoparticles using Vitex negundo methanolic extract and its anticancer efficacy in colorectal cancer. | Cytotechnology | 2025 | 40453925 | PubTator, text mining | PubMed |
| HIC1 suppresses Tumor Progression and Enhances CD8+ T Cells Infiltration Through Promoting GSDMD-induced Pyroptosis in Gastric Cancer. | Adv Sci (Weinh) | 2025 | 40279559 | PubTator, text mining | PubMed |
| COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2025 | 40198582 | PubTator, text mining | PubMed |
| The Molecular Toolbox for Linkage Type-Specific Analysis of Ubiquitin Signaling. | Chembiochem | 2025 | 40192223 | PubTator, text mining | PubMed |
| Molecular glues that inhibit deubiquitylase activity and inflammatory signaling. | Nat Struct Mol Biol | 2025 | 40097626 | PubTator, text mining | PubMed |
| Integrative analysis of serum proteomics and transcriptomics in hepatitis C. | Virol J | 2025 | 40082995 | PubTator, text mining | PubMed |
| Deubiquitinase dynamics: methodologies for understanding substrate interactions. | BMB Rep | 2025 | 40058876 | PubTator, text mining | PubMed |
| Discovery of New Azaindole Metallo-Deubiquitinase CSN5 Inhibitors. | J Med Chem | 2025 | 40053484 | PubTator, text mining | PubMed |
| Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual-Targeting BMI1 for Senescence Induction and CSN5 for PD-L1 Degradation. | Adv Sci (Weinh) | 2025 | 39721027 | PubTator, text mining | PubMed |
| COPS5 regulates osteosarcoma progression by upregulating KHSRP to promote Per2 mRNA decay. | Exp Cell Res | 2025 | 39608480 | PubTator, text mining | PubMed |
| Calpain 2 promotes Lenvatinib resistance and cancer stem cell traits via both proteolysis-dependent and independent approach in hepatocellular carcinoma. | Mol Biomed | 2024 | 39739077 | PubTator, text mining | PubMed |
| Increased CSN5 expression enhances the sensitivity to lenalidomide in multiple myeloma cells. | iScience | 2024 | 39687025 | PubTator, text mining | PubMed |
| TarKG: a comprehensive biomedical knowledge graph for target discovery. | Bioinformatics | 2024 | 39392404 | PubTator, text mining | PubMed |
| Involvement of the Constitutive Photomorphogenesis 9 Signalosome Subunit 5 With Programmed Cell Death Protein 1 Ligand in Asthma. | Allergy Asthma Immunol Res | 2024 | 39363769 | PubTator, text mining | PubMed |
| Retraction Notice to: LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM24. | Mol Ther Nucleic Acids | 2024 | 39310881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10987/papers?page=3